Dyadic International DYAI
NASDAQ DYAI
$0.49 -0.02 (-4.58%)
As of: Sep 10, 2026 · 3:01 PM EDT

Dyadic International (DYAI) Receivables - Net (2017 - 2026)

Dyadic International's (DYAI) quarterly Receivables - Net came in at $996464.0 in Q1 2026, up 349.43% year-over-year from $221719.0 in Q1 2025, and down 8.61% quarter-over-quarter from $1.1 million in Q4 2025.

Analysis

Dyadic International (DYAI) Receivables - Net (2017 - 2026) Analysis & Trends

Dyadic International has disclosed Receivables - Net across 10 years of filings, most recently posting $996464.0 for Q1 2026.

  • In Q1 2026, Receivables - Net rose 349.43% year-over-year to $996464.0; the TTM figure through Mar 2026 stood at $996464.0 (up 349.43% YoY), while the FY2025 annual figure was $1.1 million, up 359.99% from the prior year.
  • Receivables - Net came in at $996464.0 for Q1 2026 at Dyadic International, down from $1.1 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $528.2 million in Q1 2022 to a low of $121000.0 in Q4 2022.
  • Average Receivables - Net over 5 years is $31.6 million, with a median of $417878.0 recorded in 2023.
  • Year-over-year, Receivables - Net jumped 137095.26% in 2022 and tumbled 99.86% in 2023.
  • Over 5 years, Receivables - Net stood at $121000.0 in 2022, then soared by 76.03% to $213000.0 in 2023, then rose by 11.28% to $237027.0 in 2024, then jumped by 359.99% to $1.1 million in 2025, then retreated by 8.61% to $996464.0 in 2026.
  • Per Business Quant data, the three most recent Receivables - Net figures were $996464.0 in Q1 2026, $1.1 million in Q4 2025, and $916574.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 207.01 Bn 193.02 Bn 7.24 Bn
2 Gilead Sciences 179.98 Bn 176.80 Bn 6.22 Bn
3 Vertex Pharmaceuticals 131.45 Bn 123.60 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.02 Bn 74.03 Bn 3.93 Bn
5 Argenx Se 60.35 Bn 55.16 Bn 1.37 Bn
6 Moderna 53.69 Bn 48.55 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.11 Bn 29.80 Bn 992.69 Mn
8 Biogen 31.93 Bn 30.64 Bn 1.96 Bn
9 Roivant Sciences 29.21 Bn 29.21 Bn 1.16 Mn
10 Dyadic International 17.65 Mn 9.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 996,464.00
Dec 31, 2025 1.09 Mn
Sep 30, 2025 916,574.00
Jun 30, 2025 715,317.00
Mar 31, 2025 221,719.00
Dec 31, 2024 237,027.00
Sep 30, 2024 352,934.00
Jun 30, 2024 249,806.00
Mar 31, 2024 246,138.00
Dec 31, 2023 213,000.00
Sep 30, 2023 417,878.00
Jun 30, 2023 767,597.00
Mar 31, 2023 754,098.00
Dec 31, 2022 121,000.00
Sep 30, 2022 235,368.00
Jun 30, 2022 1.15 Mn
Mar 31, 2022 528.15 Mn
Dec 31, 2021 157,000.00
Sep 30, 2021 180,000.00
Jun 30, 2021 291,435.00